Key issues in F2-isoprostane analysis
- 19 September 2008
- journal article
- review article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 36 (5) , 1060-1065
Abstract
A large body of evidence indicates that measurement of F2-isoprostanes, specific prostaglandin F2-like compounds derived from the non-enzymatic peroxidation of arachidonic acid, is a reliable biomarker of oxidant stress in the human body. Since the discovery of F2-isoprostanes in the early 1990s, a variety of analytical approaches has been introduced for the quantification of these novel compounds. The aim of the present review is to shed light on the available gas chromatographic–mass spectrometric assays for the measurement of plasma or urinary F2-isoprostanes and to highlight a number of issues which need to be addressed in order to implement F2-isoprostane measurement as a gold-standard biomarker of oxidative stress in biological samples.Keywords
This publication has 48 references indexed in Scilit:
- Human Biochemistry of the Isoprostane PathwayJournal of Biological Chemistry, 2008
- Impact of diabetic polyneuropathy and cardiovascular autonomic neuropathy on the excretion of urinary 8-epi-PGF2αand its metabolites (2, 3-dinor and 2, 3-dinor-5, 6-dihydro)Free Radical Research, 2006
- Involvement of Thromboxane Receptor in the Proatherogenic Effect of Isoprostane F 2α -IIICirculation, 2005
- Urinary 8-epi-PGF2α and its endogenous β-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stressBiochemical and Biophysical Research Communications, 2005
- Rapid preparation of human urine and plasma samples for analysis of F2-isoprostanes by gas chromatography-mass spectrometryBiochemical and Biophysical Research Communications, 2004
- Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?British Journal of Pharmacology, 2004
- Plasma 8‐epi‐PGF2α levels are elevated in individuals with non‐insulin dependent diabetes mellitusFEBS Letters, 1995
- Formation of F2‐isoprostanes during aortic endothelial cell‐mediated oxidation of low density lipoproteinFEBS Letters, 1994
- Formation of PGF2-Isoprostanes During the Oxidative Modification of Low Density LipoproteinBiochemical and Biophysical Research Communications, 1994
- Inhibition of prostaglandin synthesis in manBiochemical and Biophysical Research Communications, 1972